BioDuro has launched a new Business Unit dedicated to advancing peptide drug discovery and development for its global biopharma partners.

Blackstone sold a 9.5% stake in IT firm Mphasis for Rs 4,726 crore, reducing its holding to 30.64%. Meanwhile, Bain Capital ...

Can UK science really spawn a $1-trillion company? That’s not to downplay the successes. The United Kingdom is ranked fourth ...

The healthcare sector was a contrarian pick for SoFi's Liz Thomas this year, that could come into its own in 2026. Year-end angst just keeps hitting investors, with no signs of dip-buying after Monday ...

Jefferies London Healthcare Conference 2025 November 18, 2025 8:30 AM ESTCompany ParticipantsOlivier Loeillot - President, ...

A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of ...

Discovery in U.S. litigation, especially document review, can often be a lengthy and expensive process. This naturally raises ...

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

An updated edition of the Sept. 18, 2025, article. Genomics is a comprehensive study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Given the recent promising breakthroughs ...

Under the terms of the agreements, NetraMark’s proprietary NetraAI platform will be applied to clinical data from four pivotal studies to help uncover and characterize patient subpopulations that ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with ...

Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based ...